<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03979222</url>
  </required_header>
  <id_info>
    <org_study_id>ECMO-001</org_study_id>
    <nct_id>NCT03979222</nct_id>
  </id_info>
  <brief_title>Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.</brief_title>
  <acronym>NHS ECMO</acronym>
  <official_title>Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Papworth Hospital Clinical Trials Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bioscience Statistics Unit, Institute of Public Health, University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aberdeen Royal Infirmary, NHS Grampian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Papworth Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals of Leicester NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Manchester University NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NHS England</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cambridge</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study of outcomes of the NHS England-commissioned national
      respiratory ECMO service, which has been active at six centres since December 2011.

      The primary outcome of interest is the number of patients who survive to ICU discharge at the
      ECMO centre. The study also aims to identify factors predictive of outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent randomised and observational studies suggest there may be a role for extracorporeal
      membrane oxygenation (ECMO) in patients with severe acute respiratory failure that have not
      responded to conventional measures.

      In 2011, NHS England commissioned a national service to provide ECMO for severe respiratory
      failure at six centres across the country. Patients with severe respiratory failure are
      referred to the network if conventional measures are unsuccessful, and if accepted are
      transferred to an ECMO centre for specialist care. The criteria for admission is at the
      discretion of clinicians at each centre.

      The NHS ECMO registry has been created by cross-referencing data submitted to the
      Extracorporeal Life Support Organisation (ELSO) in Ann Arbor, Michigan, with a tracker
      document identifying patients treated within the network. Analysis has been undertaken from
      December 2018 to March 2019.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2011</start_date>
  <completion_date type="Actual">March 31, 2018</completion_date>
  <primary_completion_date type="Actual">March 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival at ECMO ICU discharge</measure>
    <time_frame>Up to 90 days.</time_frame>
    <description>The proportion of patients who are alive at discharge from the ICU at the treating ECMO centre.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ECMO treatment.</measure>
    <time_frame>Up to 90 days.</time_frame>
    <description>The time (hours) where the patient is actively supported by the ECMO circuit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of Complications</measure>
    <time_frame>Up to 90 days.</time_frame>
    <description>The proportion of patients experiencing recognised complications of ECMO treatment.</description>
  </secondary_outcome>
  <enrollment type="Actual">1205</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Membrane Oxygenation</intervention_name>
    <description>ECMO provides extracorporeal gas exchange through use of a membrane oxygenator. Blood is drained from a central vein and returned after oxygenation into either the venous or arterial circulation dependent on configuration.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who received ECMO as part of the NHS England-commissioned national respiratory
        ECMO service between 1st December 2011 and 31st December 2017.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ultimately at the discretion of the clinician at the relevant ECMO centre

          -  Aged â‰¥16 years

          -  Severe acute respiratory failure refractory to conventional management

          -  No contra-indication to ongoing ECMO therapy

        Exclusion Criteria:

          -  Any contra-indication to ongoing ECMO therapy

          -  Need for ECMO due to other aetiology than acute respiratory failure (e.g. bridge to
             transplantation, extracorporeal CPR, isolated acute cardiac failure)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 2, 2019</study_first_submitted>
  <study_first_submitted_qc>June 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>August 15, 2019</last_update_submitted>
  <last_update_submitted_qc>August 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cambridge</investigator_affiliation>
    <investigator_full_name>Alex Warren</investigator_full_name>
    <investigator_title>Academic Foundation Doctor, Division of Anaesthesia</investigator_title>
  </responsible_party>
  <keyword>ECMO</keyword>
  <keyword>ARDS</keyword>
  <keyword>Acute respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT03979222/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

